Advanced search
Publication Cover
OncoTargets and Therapy Volume 13, 2020 - Issue
Submit an article Journal homepage
79
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Identification of P-Rex1 in the Regulation of Liver Cancer Cell Proliferation and Migration via HGF/c-Met/Akt Pathway

Wancheng Qiu1 Department of Pharmacy, Shanghai Fifth People’s Hospital, Fudan University, Shanghai, People’s Republic of China
,
Yanhua Chang2 Department of Pathology, The Affiliated Wuxi People’s Hospital of Nanjing Medical University, Wuxi, Jiangsu Province, People’s Republic of China
,
Jing Liu1 Department of Pharmacy, Shanghai Fifth People’s Hospital, Fudan University, Shanghai, People’s Republic of China
,
Xu Yang1 Department of Pharmacy, Shanghai Fifth People’s Hospital, Fudan University, Shanghai, People’s Republic of China
,
Yan Yu1 Department of Pharmacy, Shanghai Fifth People’s Hospital, Fudan University, Shanghai, People’s Republic of China
,
Jiajia Li1 Department of Pharmacy, Shanghai Fifth People’s Hospital, Fudan University, Shanghai, People’s Republic of China
,
Qing Liang1 Department of Pharmacy, Shanghai Fifth People’s Hospital, Fudan University, Shanghai, People’s Republic of China
&
Guangchun Sun1 Department of Pharmacy, Shanghai Fifth People’s Hospital, Fudan University, Shanghai, People’s Republic of ChinaCorrespondence[email protected] [email protected]
 show all
Pages 9481-9495 | Published online: 24 Sep 2020

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Gaurav Gupta, Waleed Hassan Al-Malki, Imran Kazmi, Lakshmi Thangavelu, Piyush Kumar Gupta, Niraj Kumar Jha, Parteek Prasher, Sachin Kumar Singh & Kamal Dua. (2021) The Role of HGF/MET in Liver Cancer. Future Medicinal Chemistry 13:21, pages 1829-1832.
Read now

Articles from other publishers (6)

Jiamin Zhang, Shu Fang, Fanghao Rong, Miaomiao Jia, Yunpeng Wang, Huixian Cui & Peipei Hao. (2023) PSMD4 drives progression of hepatocellular carcinoma via Akt/COX2 pathway and p53 inhibition. Human Cell 36:5, pages 1755-1772.
Crossref
Pengxiao Su, Ming Zhang & Xin Kang. (2023) Targeting c-Met in the treatment of urologic neoplasms: Current status and challenges. Frontiers in Oncology 13.
Crossref
L. Kumarasinghe, M.A. Garcia-Gimeno, J. Ramirez, U. Mayor, J.L. Zugaza & P. Sanz. (2023) P-Rex1 is a novel substrate of the E3 ubiquitin ligase Malin associated with Lafora disease. Neurobiology of Disease 177, pages 105998.
Crossref
Zeyu Li, Kanglin Wu, Yi Zou, Wei Gong, Peng Wang & Hong Wang. (2022) PREX1 depletion ameliorates high-fat diet-induced non-alcoholic fatty liver disease in mice and mitigates palmitic acid-induced hepatocellular injury via suppressing the NF-κB signaling pathway. Toxicology and Applied Pharmacology 448, pages 116074.
Crossref
Dali Zhao, Zhiqiang Yang, Chen Chen, Zhipeng Zhang, Yangsheng Yu & Zhituo Li. (2021) CXCR4 promotes gefitinib resistance of Huh7 cells by activating the c‐Met signaling pathway . FEBS Open Bio 11:11, pages 3115-3125.
Crossref
Elizabeth Hampson, Elpida Tsonou, Martin J. Baker, David C. Hornigold, Roderick E. Hubbard, Andrew Massey & Heidi C. E. Welch. (2021) P-Rex1 Controls Sphingosine 1-Phosphate Receptor Signalling, Morphology, and Cell-Cycle Progression in Neuronal Cells. Cells 10:9, pages 2474.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.